Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
New Zealand · Delayed Price · Currency is NZD 42.72
-0.08 (-0.19%)
Aug 14, 2026, 5:00 PM NZST
NZE:FPH Financials Overview
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,308 | 2,308 | 2,021 | 1,743 | 1,581 | 1,682 |
Revenue Growth | 6.96% | 14.22% | 15.96% | 10.23% | -5.98% | -14.69% |
Gross Profit Gross Profit Growth | 1,470 | 1,470 | 1,271 | 1,044 | 938.4 | 1,053 |
Operating Income Operating Income Growth | 636.4 | 636.4 | 509.6 | 353.4 | 332.2 | 505.6 |
Net Income Net Income Growth | 468.5 | 468.5 | 377.2 | 132.6 | 250.3 | 376.9 |
Earnings Per Share EPS Growth | 0.79 | 0.79 | 0.64 | 0.23 | 0.43 | 0.65 |
EPS Growth | 7.33% | 24.10% | 182.74% | -47.44% | -33.85% | -28.10% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Hospital Products Hospital Products Growth | 1,505 | 1,505 | 1,280 | 1,088 | 1,024 | 1,207 |
Homecare Products Homecare Products Growth | 802.7 | 802.7 | 739.9 | 652.3 | 553.8 | 469.5 |
Distributed and Other Products Distributed and Other Products Growth | 0.63 | 0.7 | 0.8 | 2.6 | 3.8 | 5.1 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 461.1 | 461.1 | 264.5 | 82 | 121.5 | 290 |
Total Debt Total Debt Growth | 146.1 | 146.1 | 153.3 | 189.1 | 145.8 | 104.3 |
Net Cash (Debt) Net Cash Growth | 315 | 315 | 111.2 | -107.1 | -24.3 | 185.7 |
Net Cash Growth | 107.51% | 183.27% | - | - | - | -27.97% |
Net Cash Per Share Net Cash Per Share Growth | 0.53 | 0.53 | 0.19 | -0.18 | -0.04 | 0.32 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 663.2 | 663.2 | 548.6 | 429.6 | 238.2 | 324.3 |
Capital Expenditures CapEx Growth | -172.8 | -172.8 | -73.6 | -316.8 | -187.8 | -138.4 |
Free Cash Flow Free Cash Flow Growth | 490.4 | 490.4 | 475 | 112.8 | 50.4 | 185.9 |
Free Cash Flow Growth | 3.16% | 3.24% | 321.10% | 123.81% | -72.89% | -60.03% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 63.69% | 63.69% | 62.89% | 59.93% | 59.35% | 62.60% |
Operating Margin | 27.57% | 27.57% | 25.21% | 20.28% | 21.01% | 30.06% |
Pretax Margin | 27.36% | 27.36% | 24.90% | 13.52% | 20.75% | 29.98% |
Profit Margin | 20.29% | 20.29% | 18.66% | 7.61% | 15.83% | 22.41% |
FCF Margin | 21.24% | 21.24% | 23.50% | 6.47% | 3.19% | 11.05% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.520 | 0.520 | 0.425 | 0.415 | 0.405 | 0.395 |
Dividend Per Share Growth | 22.35% | 22.35% | 2.41% | 2.47% | 2.53% | 3.95% |
Dividend Yield | 1.21% | 1.41% | 1.30% | 1.68% | 1.61% | 1.76% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 53.87 | 46.87 | 52.12 | 112.96 | 61.67 | 37.30 |
Forward PE | 46.57 | 42.22 | 48.68 | 47.38 | 52.48 | 39.67 |
P/FCF Ratio | 51.16 | 44.78 | 41.39 | 132.79 | 306.27 | 75.61 |
PS Ratio | 10.87 | 9.51 | 9.73 | 8.60 | 9.76 | 8.36 |